Results 81 to 90 of about 134,791 (125)

The interplay of oxytocin and dopaminergic system: Effects on food consumption in broiler chickens. [PDF]

Poult Sci
Zarei H, Sharafinezhad M, Hasani K.
europepmc   +1 more source

Dopaminergic modulation and dosage effects on brain state dynamics and working memory component processes in Parkinson's disease. [PDF]

Nat Commun
Lee B, Young CB, Cai W, Yuan R, Ryman S, Kim J, Yang L, Henderson VW, Poston KL, Menon V.   +9 more
europepmc   +1 more source

Investigating the effect of Arvcf reveals an essential role on regulating the mesolimbic dopamine signaling-mediated nicotine reward. [PDF]

Commun Biol
Wang Y, Yang Z, Shi X, Han H, Li AN, Zhang B, Yuan W, Sun YH, Li XM, Lian H, Li MD.   +10 more
europepmc   +1 more source

Parkinson's Disease: The Neurodegenerative Enigma Under the "Undercurrent" of Endoplasmic Reticulum Stress. [PDF]

Int J Mol Sci
Kong X, Liu T, Wei J.
europepmc   +1 more source

Correlation of Parkinson's disease severity and ¹⁸F-FDG and ¹⁸F-FP-DTBZ PET. [PDF]

Quant Imaging Med Surg
Li S, Lu WZ, Yan SZ, Song TB, Zhang C, Yang C, Lu J.   +6 more
europepmc   +1 more source

The effect of cannabinoid type Ⅱ receptor on the excitability of substantia nigra dopaminergic neurons. [PDF]

Front Pharmacol
Zhao S, Liu S, Gong Y, Ma Z.
europepmc   +1 more source

Chronic adulthood exposure to bisphenol A causes behavioral changes via suppressing dopamine transporter trafficking. [PDF]

Sci Rep
Shi Y, Feng X, Chung CY.
europepmc   +1 more source

The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease. [PDF]

Int J Mol Sci
ElNebrisi E, Lozon Y, Oz M.
europepmc   +1 more source

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation. [PDF]

NPJ Parkinsons Dis
Mu C, Shao K, Su M, Guo Y, Qiu Y, Sun R, Sun S, Sun Y, Liu C, Wang W, Qin X, Tang C.   +11 more
europepmc   +1 more source

Preclinical studies and transcriptome analysis in a model of Parkinson's disease with dopaminergic ZNF746 expression. [PDF]

Mol Neurodegener
Kim JH, Yang S, Kim H, Vo DK, Maeng HJ, Jo A, Shin JH, Shin JH, Baek HM, Lee GH, Kim SH, Lim KH, Dawson VL, Dawson TM, Joo JY, Lee Y.   +15 more
europepmc   +1 more source